Saturday 21 Dec, 2024 09:03 PM
Site map | Locate Us | Login
   Can Fin Homes CFO Apurav Agarwal resigns    Auro Pharma gets UK MHRA nod for cancer drug    Reliance Inds arm to acquire 45% stake in Health Alliance Group    Mazagon Dock Shipbuilders delivers two warships to Indian Navy    Dalmia Bharat's president Rajiv Bansal resigns    Cupid bags order worth Rs 18-cr from UNFPA    NTPC Green inks MoU with Govt of Bihar    IDBI Bank board to mull fund-raising proposal on Dec 31    NRB Industrial Bearings CFO Gulestan Kolah resigns    Shilpa Medicare gets GMP certification for Hyderabad Facility    Siemens Ltd leads losers in 'A' group    Restaurant Brands Asia to raise Rs 500 crore via QIP    NBCC bags orders worth Rs 298 cr for healthcare infrastructure projects    Tantia Constructions Ltd leads losers in 'B' group    Volumes soar at Aegis Logistics Ltd counter 
Saravan Stocks
       
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Stock Alert: Paytm, PC Jeweller, JSW Energy, Laurus Lab, Biocon
09-Dec-24   08:30 Hrs IST

Securities in F&O Ban:

PVR Inox, RBL Bank, Granules India, Manappuram Finance shares are banned from F&O trading on 9 December 2024.

Stocks to Watch:

PC Jeweller informed that its board will meet on Wednesday, 11 December 2024, to approve the issuance of 5,17,11,462 equity shares by way of preferential allotment on private placement basis.

JSW Energy announced that its wholly owned subsidiary JSW Neo Energy, has received a letter of award (LoA) from NTPC for the development of a 400 MW ISTS-connected solar power project.

Laurus Labs announced that its subsidiary, Laurus Bio, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital.

Power Finance Corporation's wholly owned subsidiary, PFC Consulting has incorporated a special purpose vehicle (SPV) company, NER Expansion Transmission the purpose of North-Eastern Region Expansion Scheme-XXV Part-A (NERES-XXV Part-A).

One 97 Communications (Paytm) informed that its wholly-owned subsidiary, One97 Communications Singapore (Paytm Singapore), has approved sale of stock acquisition rights (SARs) held in PayPay Corporation, Japan (PayPay) for Rs 2,364 crore.

Suven Pharmaceuticals announced that it has signed definitive agreements to acquire a 56% equity stake in NJ Bio, Inc. The $64.4 million deal includes both primary equity infusion and secondary acquisition. As part of the deal, the company will invest $15 million in primary equity to accelerate NJ Bio's growth initiatives. NJ Bio is a Contract Research, Development, and Manufacturing Organization (CRDMO) based in Princeton, New Jersey.

Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for its API facility (site 2) in Bengaluru. This report is based on a surveillance inspection conducted by the USFDA between 23rd-27th September 2024.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 37668687
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd